ATE231863T1 - 6-amino-purinderivate mit pde-iv inhibierender wirkung - Google Patents

6-amino-purinderivate mit pde-iv inhibierender wirkung

Info

Publication number
ATE231863T1
ATE231863T1 AT99100736T AT99100736T ATE231863T1 AT E231863 T1 ATE231863 T1 AT E231863T1 AT 99100736 T AT99100736 T AT 99100736T AT 99100736 T AT99100736 T AT 99100736T AT E231863 T1 ATE231863 T1 AT E231863T1
Authority
AT
Austria
Prior art keywords
purine derivatives
amino
pde
inhibiting effect
compounds
Prior art date
Application number
AT99100736T
Other languages
English (en)
Inventor
David Cavalla
Peter Hofer
Anddre Gehrig
Peter Wintergest
Mark Chasin
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE231863T1 publication Critical patent/ATE231863T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/20Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/24Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
AT99100736T 1993-06-22 1994-06-21 6-amino-purinderivate mit pde-iv inhibierender wirkung ATE231863T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939312853A GB9312853D0 (en) 1993-06-22 1993-06-22 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE231863T1 true ATE231863T1 (de) 2003-02-15

Family

ID=10737574

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99100736T ATE231863T1 (de) 1993-06-22 1994-06-21 6-amino-purinderivate mit pde-iv inhibierender wirkung
AT94918456T ATE182593T1 (de) 1993-06-22 1994-06-21 Chemische verbindungen mit pde-iv inhibitierende wirkung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT94918456T ATE182593T1 (de) 1993-06-22 1994-06-21 Chemische verbindungen mit pde-iv inhibitierende wirkung

Country Status (23)

Country Link
US (1) US5939422A (de)
EP (3) EP0705265B1 (de)
JP (1) JP3350550B2 (de)
KR (1) KR100349239B1 (de)
CN (1) CN1045778C (de)
AT (2) ATE231863T1 (de)
AU (1) AU683270B2 (de)
BG (1) BG62933B1 (de)
CA (1) CA2165433C (de)
CZ (1) CZ342595A3 (de)
DE (2) DE69419755T2 (de)
DK (1) DK0705265T3 (de)
ES (1) ES2137371T3 (de)
FI (1) FI956168A (de)
GB (1) GB9312853D0 (de)
HU (1) HUT74176A (de)
NO (1) NO955219L (de)
NZ (1) NZ267468A (de)
PL (1) PL312225A1 (de)
SK (1) SK161095A3 (de)
TW (1) TW418208B (de)
WO (1) WO1995000516A1 (de)
ZA (1) ZA944463B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0814809B1 (de) 1994-12-13 2003-08-13 Euroceltique S.A. Arylthioxanthine
DE69531555T2 (de) * 1994-12-13 2004-06-17 Euroceltique S.A. Dreifachsubstituierte thioxanthine
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US6294541B1 (en) 1996-06-06 2001-09-25 Euro-Celtique S.A. Purine derivatives having phosphodiesterase IV inhibition activity
DE69824632T2 (de) 1997-11-12 2005-06-09 Mitsubishi Chemical Corp. Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten
AU1722999A (en) 1997-12-12 1999-07-05 Euro-Celtique S.A. Preparation of 3-substituted adenines and imidazo pyridines
US6319928B1 (en) 1998-11-30 2001-11-20 Euro-Celtique, S.A. Purine derivatives having phosphodiesterase IV inhibition activity
AU4053800A (en) * 1999-04-02 2000-10-23 Euro-Celtique S.A. Purine derivatives having phosphodiesterase iv inhibition activity
WO2000068231A1 (fr) 1999-05-11 2000-11-16 Mitsubishi Chemical Corporation Dihydrate derive de purine, medicaments le contenant comme principe actif et intermediaire utilise dans sa preparation
DE60014915T2 (de) * 1999-08-12 2005-10-13 Euro-Celtique S.A. Hypoxanthin- und thiohypxanthin-verbindungen
WO2002098878A1 (en) * 2001-02-08 2002-12-12 Memory Pharmaceuticals Corporation Trifluoromethylpurines as phosphodiesterase 4 inhibitors
KR20040007583A (ko) 2001-05-23 2004-01-24 다나베 세이야꾸 가부시키가이샤 연골 질환의 재생치료용 조성물
MXPA03010679A (es) 2001-05-23 2004-03-02 Tanabe Seiyaku Co Una composicion para acelerar la cicatrizacion de fractura osea.
AR039385A1 (es) 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
CN100415747C (zh) * 2002-08-08 2008-09-03 记忆药物公司 磷酸二酯酶4抑制剂
CN1688580A (zh) * 2002-08-08 2005-10-26 记忆药物公司 作为磷酸二酯酶4抑制剂的2-三氟甲基-6-氨基嘌呤衍生物
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
TW200806667A (en) * 2006-04-13 2008-02-01 Astrazeneca Ab New compounds
WO2007120097A1 (en) * 2006-04-13 2007-10-25 Astrazeneca Ab Thioxanthine derivatives and their use as inhibitors of mpo
DK3421471T3 (da) 2006-04-25 2021-06-14 Astex Therapeutics Ltd Purin- og deazapurinderivater som farmaceutiske forbindelser
TW200804383A (en) 2006-06-05 2008-01-16 Astrazeneca Ab New compounds
TW200902025A (en) * 2007-04-11 2009-01-16 Alcon Res Ltd Use of an inhibitor of TNF α plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MY150059A (en) 2007-10-11 2013-11-29 Astrazeneca Ab Pyrrolo [2,3-d] pyrimidin derivatives as protein kinase b inhibitors
EP3239170B1 (de) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Für die behandlung von gastrointestinalen erkrankungen, entzündungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase
EP3241839B1 (de) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Zur behandlung von erkrankungen des magen-darm-trakts, entzündlichen erkrankungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase
MX2012003693A (es) * 2009-10-01 2012-04-19 Alcon Res Ltd Composiciones de olopatadine y usos de las mismas.
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
EP2694056B1 (de) 2011-04-01 2019-10-16 AstraZeneca AB Therapeutische behandlung
WO2013079964A1 (en) 2011-11-30 2013-06-06 Astrazeneca Ab Combination treatment of cancer
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
IL280864B2 (en) 2013-08-09 2024-03-01 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
EP3165224A1 (de) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Verwendung von pde4 hemmern zur prophylaxe und/oder therapie von dyslipoproteinaemie und verwandten erkrankungen
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2844577A (en) * 1958-07-22 Certificate of correction
US2956998A (en) * 1960-10-18 Adenine derivatives and process
US3215696A (en) * 1965-11-02 Substituted adenines -and preparation thereof
US2903455A (en) * 1959-09-08 Jdnviiiiaisnvhi jo
US31429A (en) * 1861-02-12 Improvement in sewing-machines
FR835818A (fr) 1938-03-28 1939-01-04 Système de soupape, spécialement pour moteurs à combustion
US2320654A (en) * 1940-08-08 1943-06-01 Riester Oskar Sensitization of photographic emulsions
US2691654A (en) * 1952-06-11 1954-10-12 Buroughs Wellcome & Co U S A I Amino heterocycles and method of making
US2966488A (en) * 1956-07-30 1960-12-27 Shive William Substituted alkylaminopurines
US2957875A (en) * 1957-11-18 1960-10-25 Upjohn Co Derivatives of purine
US3079378A (en) * 1960-02-01 1963-02-26 Upjohn Co Acylated psicofuranosyladenines
NL262940A (de) * 1960-03-31
US3135753A (en) * 1961-05-10 1964-06-02 Burroughs Wellcome Co Alkylthiopurines and method
US3129225A (en) * 1961-06-07 1964-04-14 Us Vitamin Pharm Corp Novel 4-oxy-3-maleimidyl betaines
GB967483A (de) * 1961-09-12
FR1548252A (de) * 1961-10-13 1968-12-06
US3136771A (en) * 1962-03-09 1964-06-09 Ciba Ltd Bis-(2-benzoxazolyl) furylmethy-pyridinium chloride
US3491091A (en) * 1962-03-28 1970-01-20 Boehringer & Soehne Gmbh 5-nitrofuran derivatives
US3470164A (en) * 1962-05-04 1969-09-30 Dainippon Pharmaceutical Co 2-(2-(5-nitrofuryl)-vinyl)-azoles and process for producing thereof
US3494919A (en) * 1964-07-30 1970-02-10 American Cyanamid Co Preparation of styryloxazole compounds
IL24679A (en) * 1965-11-24 1971-10-20 Yissum Res Dev Co Derivatives of 3-methyl purine and methods of preparing the same
CH465959A (de) * 1966-11-30 1969-01-15 Ciba Geigy Gebrauchsfertiges Mittel zur Bekämpfung von schädlichen Mikroorganismen auf textilem Material
CH557381A (de) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co Verfahren zur herstellung von (delta)3-cephemverbindungen.
US3681328A (en) * 1967-06-27 1972-08-01 Fujisawa Pharmaceutical Co Sydnone derivatives of 7-aminocephalosporanic acids
CH542853A (de) * 1967-07-26 1973-10-15 Agripat Sa Verfahren zur Herstellung neuer Isothiocyano-benzazol-Derivate
GB1241657A (en) * 1967-08-21 1971-08-04 Glaxo Lab Ltd Improvements in or relating to cephalosporin compounds
DE1670265A1 (de) * 1967-08-25 1971-01-28 Boehringer Mannheim Gmbh 2-Amino-Adenosinderivate und Verfahren zu deren Herstellung
US3669979A (en) * 1967-12-14 1972-06-13 Gaf Corp Novel process for the production of 2-benzothiazolyl-phenol and derivatives thereof employing phosphorus trichloride as a catalyst
US3541100A (en) * 1967-12-14 1970-11-17 American Cyanamid Co Benzheteroazolo(2,3-a)isoquinolium salts
US3491106A (en) * 1967-12-15 1970-01-20 Gaf Corp Sodium 3-(2-benzothiazolyl) - 4-hydroxy-benzenesulfonates and analogues thereof
US3626018A (en) * 1968-01-25 1971-12-07 Edward C Taylor Chemical processes using organothallium compounds
US3923833A (en) * 1968-05-01 1975-12-02 Hoffmann La Roche N-{8 (1-cyano-2-phenyl)ethyl{9 carbamates
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
CH512931A (de) 1969-03-03 1971-09-30 Ciba Geigy Ag Verwendung von Azolverbindungen als Antioxydantien
CH516339A (de) 1969-03-03 1971-12-15 Ciba Geigy Ag Verwendung von Azolverbindungen als Antioxydantien
US3647812A (en) * 1969-04-22 1972-03-07 Richard F Smith Halogenated 2(2'-hydroxyphenyl benzothiazoles
US3574218A (en) * 1969-08-11 1971-04-06 Egyt Gyogyszervegyeszeti Gyar 2-aryl- or aralkyl-substituted benzazole derivatives
US4146721A (en) * 1969-09-12 1979-03-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrazol-4-acetic acid compounds
US3666769A (en) * 1969-10-09 1972-05-30 Du Pont Thermally stable 2-perfluoro-substituted benzothiazoles
US3686238A (en) * 1970-01-19 1972-08-22 Syntex Corp Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
US3636039A (en) * 1970-02-24 1972-01-18 Hoffmann La Roche Substituted benzylimidazolidinones
FR2104932A1 (en) 1970-09-08 1972-04-28 Ferlux O-hydroxyphenyl pyrazoles - hypocholesterolemics anti inflammatories analgesics etc
US3674781A (en) * 1970-09-15 1972-07-04 Hoechst Ag Optical brighteners of the benzoxazole series
US3962452A (en) * 1972-05-18 1976-06-08 Lilly Industries, Ltd. Benzoxazole derivatives as therapeutics
US3895028A (en) 1972-09-12 1975-07-15 Tokyo Tanabe Co Alpha-(2-phenylbenzothiazol-5-yl)propionic acid
CA994351A (en) 1973-01-11 1976-08-03 E.R. Squibb And Sons Tetrahydronaphthyloxy-amines and related compounds
US4107306A (en) * 1973-01-16 1978-08-15 The Regents Of The University Of Michigan Process for treating proliferative skin disease
US4025636A (en) * 1973-10-23 1977-05-24 Lilly Industries, Ltd. 2-(Optionally substituted)phenyl-5 or 6-substituted benzoxazoles
US4025637A (en) * 1973-10-23 1977-05-24 Lilly Industries, Ltd. 2,5 OR 2,6 Disubstituted benzoxazoles
DE2413935A1 (de) 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
JPS5120826A (en) * 1974-08-13 1976-02-19 Fuji Photo Film Co Ltd Shashinyokapuraa
JPS5154587A (en) * 1974-11-05 1976-05-13 Kyowa Gas Chem Ind Co Ltd Purinkeikagobutsuno seizohoho
US4020165A (en) * 1975-08-20 1977-04-26 Uniroyal Inc. Control of acarids using certain benzothiazoles or benzothiazolines
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
LU76467A1 (de) * 1976-12-23 1978-07-10
USRE31429E (en) 1977-02-14 1983-10-25 Merck & Co., Inc. Process for preparation of 9-(dihalobenzyl)adenines
DE2714953C2 (de) 1977-04-02 1986-09-25 Hoechst Ag, 6230 Frankfurt Arzneimittel
SE416810C (sv) * 1977-10-14 1982-05-11 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
HU179019B (en) * 1978-11-01 1982-08-28 Gyogyszekutato Intezet Process for preparing 4-//3,4-dialkoxy-phenyl/-alkyl/- 2imidazolidinone derivatives
GB2041359B (en) * 1979-01-10 1982-12-15 Ici Ltd Purine derivatives and their use in the defoliation of cotton plants
US4684728A (en) * 1979-01-12 1987-08-04 Bayer Aktiengesellschaft Solubilizing biologically active compounds with reactive hydrogen atoms
IL59665A0 (en) 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
US4241063A (en) * 1979-08-06 1980-12-23 Bristol-Myers Company Purine derivatives and their use as bronchodilators
CH643260A5 (fr) * 1980-05-02 1984-05-30 Nestle Sa 1-allyl-3-butyl-8-methylxanthine, procede de preparation et utilisation dans un medicament.
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4416892A (en) * 1981-04-23 1983-11-22 Lilly Industries Limited Method of treating hypersensitivity disease with benzoxazole derivatives
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4407802A (en) * 1981-09-28 1983-10-04 Merck & Co., Inc. 6-Amidino-9-substituted benzyl purines
US4361699A (en) * 1981-09-28 1982-11-30 Merck & Co., Inc. Novel process for the preparation of N6 -alkyl-arprinocid
US4495195A (en) * 1982-11-01 1985-01-22 Eli Lilly And Company Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use
US4769377A (en) * 1983-02-18 1988-09-06 The Johns Hopkins University Adenosine receptor antagonists
JPS60260579A (ja) * 1984-01-13 1985-12-23 Yoshitomi Pharmaceut Ind Ltd プリン誘導体
US4918074A (en) * 1984-03-12 1990-04-17 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocycle compounds
DE3575130D1 (de) * 1984-05-12 1990-02-08 Fisons Plc Antiinflammatorische 1,n-diarylpyrazol-3-amine, deren zusammensetzungen und verfahren zu deren herstellung.
JPS615071A (ja) * 1984-06-15 1986-01-10 Fuji Photo Film Co Ltd ベンゾオキサゾ−ル誘導体
IN165525B (de) * 1984-07-23 1989-11-04 Shinetsu Chemical Co
EP0178413A1 (de) 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazole
US4883801A (en) * 1984-09-07 1989-11-28 The General Hospital Corporation Xanthine derivative pest control agents
IT1177017B (it) * 1984-10-22 1987-08-26 Ravizza Spa Processo per la preparazione dell'acido 2(4-flurofenil)alfa-metil-5-benzox azoloacetico
US4710503A (en) * 1985-02-07 1987-12-01 Euroceltique S.A. 6-thioxanthine derivatives
JPH0658512B2 (ja) * 1985-04-12 1994-08-03 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
US4732978A (en) * 1985-10-03 1988-03-22 American Home Products Corporation Novel substituted naphthyloxymethyl quinoline derivatives as anti-inflammatory and antiallergy agents
US4684656A (en) * 1986-03-14 1987-08-04 E. R. Squibb & Sons, Inc. 1,2,3,4-tetrahydro-6-substituted-4-aryl-3-(substituted sulfonyl)-2-thioxo(or oxo)-5-pyrimidinecarboxylic acids and esters and method of using them to lower blood pressure
DE3773746D1 (en) * 1986-05-07 1991-11-21 Fisons Plc Pyrazole.
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
US4868183A (en) * 1986-07-21 1989-09-19 Otsuka Pharmaceutical Factory, Inc. N-pyrazinyl substituted P-aminophenols
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
GB8618931D0 (en) 1986-08-02 1986-09-10 Euro Celtique Sa 6-thioxanthines
ES2033922T3 (es) 1986-08-28 1993-04-01 Sandoz Ag Procedimiento para preparar nuevos derivados de xantina.
JPH0612406B2 (ja) * 1986-11-14 1994-02-16 富士写真フイルム株式会社 超硬調ネガ型ハロゲン化銀写真感光材料
CA1340284C (en) * 1987-03-19 1998-12-22 Zeneca Inc. Herbicidal substituted cyclic diones
US5057517A (en) * 1987-07-20 1991-10-15 Merck & Co., Inc. Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
JPH0670025B2 (ja) * 1987-08-07 1994-09-07 鐘紡株式会社 ベンゾチアゾ−ル誘導体および該化合物を有効成分とする抗リウマチ剤
JPH01121854A (ja) * 1987-11-06 1989-05-15 Fuji Photo Film Co Ltd 高コントラストネガ画像形成方法
JPH07117726B2 (ja) * 1987-12-17 1995-12-18 富士写真フイルム株式会社 ハロゲン化銀感光材料
US5139921A (en) * 1988-01-11 1992-08-18 Fuji Photo Film Co., Ltd. Process for forming super high contrast negative images
US5091431A (en) * 1988-02-08 1992-02-25 Schering Corporation Phosphodiesterase inhibitors
JPH01213650A (ja) * 1988-02-20 1989-08-28 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料の処理方法
JPH07113758B2 (ja) * 1988-03-28 1995-12-06 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
IE940525L (en) 1988-05-25 1989-11-25 Warner Lambert Co Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
GB8820231D0 (en) * 1988-08-25 1988-09-28 Fujisawa Pharmaceutical Co New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same
IL91418A (en) * 1988-09-01 1997-11-20 Rhone Poulenc Agrochimie (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them
EP0363320A3 (de) * 1988-10-06 1991-11-21 Ciba-Geigy Ag Substituierte 9H-Purine
GB8826595D0 (en) 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
IT1229195B (it) 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
US4971972A (en) * 1989-03-23 1990-11-20 Schering Corporation Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
GB8909558D0 (en) 1989-04-26 1989-06-14 Smith Kline French Lab Chemical compounds
US5290782A (en) * 1989-09-01 1994-03-01 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
JPH03173874A (ja) * 1989-09-29 1991-07-29 Mitsubishi Kasei Corp 新規複素環化合物
US5270206A (en) * 1989-11-13 1993-12-14 Pfizer Inc. Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
GB8929208D0 (en) 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
US5124455A (en) 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
US5117830A (en) * 1990-11-08 1992-06-02 Whitby Research, Inc. Method of determining viability of tissue
CA2098912A1 (en) 1990-12-28 1992-06-29 Tatsuki Shiota Benzoxa condensed ring compound, process for producing the same and pharmaceutical composition comprising the same
IE71647B1 (en) 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
US5177074A (en) * 1991-03-26 1993-01-05 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5190942A (en) * 1991-04-22 1993-03-02 E. R. Squibb & Sons, Inc. Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives
US5191084A (en) 1991-05-01 1993-03-02 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
US5264589A (en) * 1991-06-06 1993-11-23 Miles Inc. Merocyanine protein error indicators
DE4129603A1 (de) 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5827868A (en) 1991-10-07 1998-10-27 E. R. Squibb & Sons, Inc. Prostaglandin analogs
US5288896A (en) * 1992-01-15 1994-02-22 Warner-Lambert Company 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor
US5552438A (en) 1992-04-02 1996-09-03 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
DE69328778T2 (de) 1992-04-02 2000-11-23 Smithkline Beecham Corp Verbindungen für die behandlung von entzündlichen erkrankungen und zur hemmung der produktion von tumornekrosefaktor
WO1993019747A1 (en) 1992-04-02 1993-10-14 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
US5436258A (en) 1992-09-09 1995-07-25 Eli Lilly And Company Prevention of bone resorption
JP2613355B2 (ja) 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
US5322847A (en) * 1992-11-05 1994-06-21 Pfizer Inc. Azabenzimidazoles in the treatment of asthma, arthritis and related diseases
US5451596A (en) 1992-12-29 1995-09-19 Rhone Poulenc Rorer Pharmaceuticals Inc. Cycloalkyl amine bis-aryl squalene synthase inhibitors
US5395836A (en) 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9309324D0 (en) 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
CA2131680C (en) 1993-09-17 2006-11-07 Gerhard Stucky Process for preparing imidazopyridine derivatives
US5446046A (en) 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
GB9322828D0 (en) 1993-11-05 1993-12-22 Sandoz Ltd Organic compounds
CA2143143A1 (en) 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives
FI951367A (fi) 1994-03-28 1995-09-29 Japan Energy Corp Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit)
US5424432A (en) * 1994-05-26 1995-06-13 Merck & Co., Inc. Process for the preparation of imidazolutidine
HRP950288A2 (en) 1994-05-31 1997-08-31 Bayer Ag Oxalylamino-benzofuran- and benzothienyl-derivatives
GB9410877D0 (en) 1994-05-31 1994-07-20 Bayer Ag Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
US5869486A (en) 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
GB9504460D0 (en) 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
GB9525262D0 (en) 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas

Also Published As

Publication number Publication date
KR100349239B1 (ko) 2003-01-24
CA2165433C (en) 2002-05-28
ZA944463B (en) 1995-02-17
CN1125445A (zh) 1996-06-26
TW418208B (en) 2001-01-11
HU9503545D0 (en) 1996-02-28
US5939422A (en) 1999-08-17
DE69419755T2 (de) 2000-02-17
EP0705265A1 (de) 1996-04-10
NZ267468A (en) 1997-11-24
NO955219D0 (no) 1995-12-21
CA2165433A1 (en) 1994-12-23
DK0705265T3 (da) 2000-03-13
JP3350550B2 (ja) 2002-11-25
AU6977194A (en) 1995-01-17
EP0916673A1 (de) 1999-05-19
AU683270B2 (en) 1997-11-06
DE69432087T2 (de) 2003-11-06
BG100258A (bg) 1996-11-29
EP0916673B1 (de) 2003-01-29
ES2137371T3 (es) 1999-12-16
GB9312853D0 (en) 1993-08-04
NO955219L (no) 1996-02-22
EP0916672A1 (de) 1999-05-19
FI956168A (fi) 1996-02-01
EP0705265B1 (de) 1999-07-28
ATE182593T1 (de) 1999-08-15
SK161095A3 (en) 1997-01-08
FI956168A0 (fi) 1995-12-21
DE69419755D1 (de) 1999-09-02
DE69432087D1 (de) 2003-03-06
CN1045778C (zh) 1999-10-20
KR960703124A (ko) 1996-06-19
JPH09500376A (ja) 1997-01-14
CZ342595A3 (en) 1996-08-14
PL312225A1 (en) 1996-04-01
WO1995000516A1 (en) 1995-01-05
HUT74176A (en) 1996-11-28
BG62933B1 (bg) 2000-11-30

Similar Documents

Publication Publication Date Title
ATE231863T1 (de) 6-amino-purinderivate mit pde-iv inhibierender wirkung
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
BG103417A (en) Condensed pyrimidine bicyclic derivatives
DE69520364T2 (de) Benzothepines mit wirkung als inhibitoren des gallensäuretransports und der taurocholate-aufnahme
DE3876877T2 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE3688038D1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
NZ217016A (en) Zwitterionic bicyclic heterocyclic compounds, and pharmaceutical compositions containing such
MX9200396A (es) Derivados de benciloxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DE69713300T2 (de) Benzopyran derivate mit leukotrien-antagonistischer wirkung
DE69005860T2 (de) Verwendung von 5'-Deoxy-5'-methylthioadenosin S-adenosylmethionin und dessen Salzen zur Herstellung von Seborrhea vermindernden Arzneimitteln.
DE58904029D1 (de) Verwendung eines gemisches zur behandlung der alopezie.
DE69206102D1 (de) Di(2-propyl)ester von 1-fluoro-2-phosphonomethoxy-3-p-toluol-sulfonyloxypropan, deren herstellung und vervendung.
HUP0203045A2 (hu) Epesavval képezett 4-benzil-amino-kinolin konjugátumok és hetero-analógjai, valamint eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények, és ezek alkalmazása
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
ITMI911845A1 (it) Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
DE69630876D1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
DE69429538T2 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
GR3024709T3 (en) Novel cytarabine derivatives, their production and use
ATA16784A (de) Verwendung von 3-substituierten tetrahydropyrrolo(1,2-a)pyrimidin-derivaten sowie von deren saeureadditions- und quaternaeren salzen zur herstellung von pharmazeutischen praeparaten
IT1213033B (it) Esteri di n-alchil-nortropine eloro derivati ammonioquaternari aventi attivita'anti-broncospastica, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0916673

Country of ref document: EP

REN Ceased due to non-payment of the annual fee